The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, producing billions in sales , its exclusivity period created a flood of generic competition , significantly eroding its dominance. While specific pharmaceutical companies may attempt to capitalize on male sexual dysfunction